tizanidine 0.4 MG/ML Oral Solution [Ontralfy]
- RxCUI
- 2709438
- RxNorm name
- tizanidine 0.4 MG/ML Oral Solution [Ontralfy]
- Display name
- tizanidine 0.4 MG/ML Oral Solution [Ontralfy]
- Full name
- tizanidine 0.4 MG/ML Oral Solution [Ontralfy]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:05
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ontralfy | TIZANIDINE HYDROCHLORIDE | Rosemont Pharmaceuticals, LLC | 7b88c338-c0b7-4c08-bef6-a4ffc2f25df7 | 2025-10-25 | Warnings, Adverse reactions | 2709438 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 7b88c338-c0b7-4c08-bef6-a4ffc2f25df7 | Ontralfy 2 MG in 5 mL Oral Solution [PSN] · tizanidine 0.4 MG/ML Oral Solution [Ontralfy] [SBD] · Ontralfy 0.4 MG/ML Oral Solution [SY] · Ontralfy 2 MG per 5 mL Oral Solution [SY] | 4 | 2 | These highlights do not include all the information needed to use ONTRALFY™ safely and effectively. See full prescribing information for ONTRALFY. ONTRALFY™ (tizanidine oral solution) Initial U.S. Approval: 1996 | 20251025 |